Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Cardima in Europe

This article was originally published in The Gray Sheet

Executive Summary

Revelation Helix STX, the "large loop" version of Revelation Helix, features 16 3 mm electrodes for better tissue contact in treating atrial fibrillation in patients with larger pulmonary veins, according to the Fremont, Calif. company. Helix STX is the fifth product in the Revelation line to receive European CE mark authorization, the company announces July 10. Cardima is in discussions with FDA on how to revive a PMA for the Revelation Tx, following a negative advisory panel review in May (1"The Gray Sheet" June 23, 2003, In Brief)...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT018681

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel